Jubilant Life Sciences has informed about issue of unsecured high yield bonds by the wholly-owned subsidiary Jubilant Pharma (a Company incorporated under the laws of Singapore), outside India, under Regulations of the US Securities Act of 1933 (the US Securities Act).
The above information is a part of company’s filings submitted to BSE.